Hp Carevue 9000 Clinical Information System, Model M2331A
510(k) K992636
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK992636 | Date31 Aug 1999 | StatusActive |
Recalls
-
- Terminated Z-3111-2011
Under certain circumstances, edits to an order can result in unintended scheduled interventions on the IntelliVue Clinical Information Portfolio. A patient may receive interventions or additional medication doses that are not intended.
-
- Terminated Z-2175-2011
Edits to an order can result in unintended scheduled interventions and a patient may receive additional interventions or medication doses that are not intended.
-
- Terminated Z-0414-2011
Software: Scheduling function of the Philips Intellivue Clinical Information Portfolio Releases D.00 through D.03. Edits to a scheduled even frequency order may result in pending interventions not being generated after the first 24 hours.
-
- Terminated Z-0418-2010
A software defect exists in the ICIP Release 0.02 scheduling function for order management such that if a user edits either the Schedule Time or the Stop Time for an existing order, the corresponding intervention(s) for the order may not be created.
-
- Terminated Z-1654-2009
Error in therapy scheduling: If scheduled orders are documented and edited prior to the orders' original schedule time, ICIP can create a second instance of the same order marked as pending. A second instance of an order may result in a patient receiving duplicate therapy or patients may not receive their scheduled therapies.
-
- Terminated Z-1436-2009
Software: A software defect under certain circumstances could lead to the unintended administration of a duplicate dose of a scheduled medication within a single 24 hour period
-
- Terminated Z-1541-2008
- Terminated Z-1540-2008
Medications prescribed for one patient were printed on the record of another patient.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2450
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent